姓    名： 伍小云

职    称： 教授，博士，博士生导师

联系方式： 南方医科大学药学院

Email:  xywu@smu.edu.cn

主要招生方向：药物化学、工业药学

学习经历：

2001.09-2006.07 湖南大学化学化工学院，硕博连读，博士

1997.09-2001.07 湖南大学化学化工学院，本科

工作经历:

2019.06- 南方医科大学药学院，教授

2013.12-2019.06 南方医科大学药学院，副教授

2006.12-2013.12 南方医科大学药学院，讲师

研究方向:

计算机辅助的小分子酪氨酸激酶抑制剂的设计、合成及生物活性评价

承担课程：

《药物化学》,《药物设计学》,《计算机辅助药物设计》（研究生课程）

主要科研课题：

1.国家自然科学基金面上基金（81872740），可克服T790M和C797S耐药的EGFR变构抑制剂的设计、合成及生物活性评价，2019.1-2022.12，项目负责人。

2.国家自然科学基金青年基金（81202413），靶向VEGFR-2的II型小分子抑制剂的设计、合成及构效关系研究，2013.1-2015.12，项目负责人，已结题。

主要论著：

1. Wan Shanhe, Yan Ruohong, Jiang Ying, Li Zhonghuang, Zhang Jiajie*, Wu Xiaoyun*. Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy calculations. J Biomol Struct Dyn, 2019: 37(16):4384-94.

2. Tian Yuanxin, Zhang Ttingting, Long Lifan, Zhonghuang Li, Shanhe Wan, Guangfa Wang, Yonghuan Yu, Ju Hou, Xiaoyun Wu*, Jiajie Zhang*. Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors. Eur J Med Chem, 2018:143:182-99.

3. Wang Yuanyuan, Wan Shanhe, Li Zhonghuang,Yu Fu, Guangfa Wang, Jiajie Zhang*,Xiaoyun Wu*. Design, synthesis, biological evaluation and molecular modeling of novel 1H -pyrazolo[3,4-d]pyrimidine derivatives as BRAF V600E and VEGFR-2 dual inhibitors. Eur J Med Chem, 2018; 155:210-28.

4. Wu Xiaoyun*, Wang Yuanyuan, Wan Shanhe, Zhang Jiajie*. Investigation on the binding mechanism of loratinib with the c-ros oncogene 1 (ROS1) receptor tyrosine kinase via molecular dynamics simulation and binding free energy calculations. J Biomol Struct Dyn, 2018 ，36(12):3106-13.

5. Wu Xiaoyun*, Fu Yu, Wang Yuanyuan, Wan Shanhe, Zhang Jiajie*. Computational investigation on inhibition mechanism of BRAFV600E by Vemurafenib (PLX4032) and its analogue PLX4720. Med Chem Res, 2017，26(2):390-6.

6. Fu Yu, Wang Yuanyuan, Wan Shanhe, Zhonghuang Li, Guangfa Wang, Jiajie Zhang * and Xiaoyun Wu *. Bisarylureas Based on 1H-Pyrazolo[3,4-d]pyrimidine Scaffold as Novel Pan-RAF Inhibitors with Potent Anti-Proliferative Activities: Structure-Based Design, Synthesis, Biological Evaluation and Molecular Modelling Studies. Molecules, 2017, 22(4):542.

7. Wu Xiaoyun, Fu Yu, Wang Yuanyuan, Wan Shanhe, Zhang Jiajie. Gaining insight into crizotinib resistance mechanisms caused by L2026M and G2032R mutations in ROS1 via molecular dynamics simulations and free-energy calculations. J Mol Model, 2017, 23(4):141-6.

8. Hou Ju , Wan Shanhe , Wang Guangfa, Zhang Tingting, Li Zhonghuang, Tian Yuanxin, Yu Yonghuan, Wu Xiaoyun **, Zhang Jiajie* . Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor. Eur J Med Chem , 2016,118:276-289.

9. Wu XiaoYun ∗, Wan ShanHe, Wang GuangFa, Jin Hong, Li ZhongHuang, Tian YuanXin, Zhu ZhengGuang, Zhang JiaJie ∗. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2. J Mol Graph Model, 2015, 56: 103–112.